Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499887 · ClinicalTrials.gov registry record · NA
Repeat Emergency Department Visits Among Patients With Asthma and COPD
A NA study, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02499887 is a NA study that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 6 participants.
The verdict
NCT02499887, a NA study, was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to determine whether the addition of inhaled corticosteroids to treatment with oral corticosteroids and albuterol would reduce repeat emergency department (ED) visits among patients treated for acute exacerbations of asthma and COPD discharged from the emergency department to home. The investigators hypothesize that patients treated with inhaled corticosteroids in addition to oral corticosteroids and albuterol will have lower rates of 30-day return visits to the emergency department than those patients treated with oral corticosteroids and albuterol only.
Interventions
- DRUG Prednisone
- DRUG albuterol
- DRUG beclamethasone dipropionate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02499887
The ClinicalTrials.gov registry entry for NCT02499887 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Prednisone is the first listed.
NCT02499887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02499887 about?
NCT02499887 is a clinical study titled "Repeat Emergency Department Visits Among Patients With Asthma and COPD". The purpose of the proposed study is to determine whether the addition of inhaled corticosteroids to treatment with oral corticosteroids and albuterol would reduce repeat emergency department (ED) visits among patients treated for acute exacerbations of asthma and COPD discharged from the emergency ...
What is the current status of trial NCT02499887?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-01. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02499887?
The interventions under investigation include: Prednisone (DRUG), albuterol (DRUG), beclamethasone dipropionate (DRUG).
Who is sponsoring clinical trial NCT02499887?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.